These findings provide important new insights into understanding the roles that HA-CD44-mediated PKCε activation and Nanog-regulated miR-21 play in regulating anti-apoptosis and chemotherapy resistance in breast tumor cells. The gene discussed is CD44; the disease is breast neoplasm.